πŸ‡ΊπŸ‡Έ FDA
Patent

US 10188614

Particulate materials

granted A61KA61K31/137A61K31/48

Quick answer

US patent 10188614 (Particulate materials) held by Nektar Therapeutics expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K31/137, A61K31/48, A61K31/485, A61K31/4985